High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy. | J Clin Med;13(16)2024 Aug 13. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy.

Persaud, Natasha V; Park, Jeong A; Cheung, Nai Kong V.

Affiliation

Persaud NV; Department of Pediatrics Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Park JA; Pediatrics Inha University Hospital, Icheon 22332, Republic of Korea.
Cheung NKV; Department of Pediatrics Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

J Clin Med ; 13(16)2024 Aug 13.

Article in En | MEDLINE | ID: mdl-39200906

Key words

adoptive cellular therapy; ex vivo armed T cell with bispecific antibody (EAT); high-risk neuroblastoma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland